Largest health care pharmaceutical companies by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 health care pharmaceutical companies ranked by total debt, at ZAR 1.18T, ahead of Pfizer (ZAR 1.14T) and Merck & Co (ZAR 863.7B). Figures as of 20 Nov 2026, 01:20 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieZAR 1.18T
- Median
- ZAR 92.4B
- Combined market value
- ZAR 86.94T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | ZAR 1.18T | ZAR 8.78T | ZAR 4,967.51 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | ZAR 1.14T | ZAR 2.75T | ZAR 482.49 | 1.85% down | 15% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 863.7B | ZAR 5.74T | ZAR 2,326.78 | 3.61% down | 45% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | ZAR 839.9B | ZAR 11.27T | ZAR 4,680.19 | 2.04% down | 34% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | ZAR 790.3B | ZAR 2.09T | ZAR 1,022.09 | 2.05% down | 30% up | ||
| 6 | Eli LillyLLY · Health Care | ZAR 744.6B | ZAR 21.08T | ZAR 23,671.08 | 2.29% down | 33% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | ZAR 535.6B | ZAR 1.2T | ZAR 375.09 | 0.66% up | 51% up | ||
| 8 | AstraZenecaAZN · Health Care | ZAR 519B | ZAR 4.77T | ZAR 3,073.11 | 1.87% down | 1% up | ||
| 9 | NovartisNVS · Health Care | ZAR 503.3B | ZAR 5T | ZAR 2,649.31 | 2.57% down | 25% up | ||
| 10 | SanofiSNY · Health Care | ZAR 363.5B | ZAR 1.94T | ZAR 806.95 | 2.25% down | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | ZAR 340.5B | ZAR 3T | ZAR 680.99 | 1.42% down | 17% down | ||
| 12 | GSKGSK · Health Care | ZAR 336.1B | ZAR 1.68T | ZAR 837.79 | 1.56% down | 5% up | ||
| 13 | ViatrisVTRS · Health Care | ZAR 252.5B | ZAR 399.3B | ZAR 348.29 | 1.97% down | 99% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | ZAR 226.5B | ZAR 3.15T | ZAR 1,819.76 | 0.58% down | 16% down | ||
| 15 | ZoetisZTS · Health Care | ZAR 158.4B | ZAR 575.1B | ZAR 1,415.41 | 5.59% down | 26% down | ||
| 16 | Royalty PharmaRPRX · Health Care | ZAR 156.8B | ZAR 682.2B | ZAR 1,186.43 | 1.38% down | 79% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 93.9B | ZAR 265.9B | ZAR 4,142.51 | 4.57% down | 41% up | ||
| 18 | GenmabGMAB · Health Care | ZAR 92.4B | ZAR 554.7B | ZAR 899.63 | 0.75% up | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | ZAR 70.4B | ZAR 230.2B | ZAR 460.59 | 1.54% down | 26% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 45.1B | ZAR 130.6B | ZAR 374.74 | 2.24% down | 90% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | ZAR 35.2B | ZAR 266.8B | ZAR 1,369.68 | 0.22% up | 21% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 34.8B | ZAR 1.67T | ZAR 16,176.55 | 2.35% down | 28% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | ZAR 31.8B | ZAR 79.4B | ZAR 476.88 | 0.62% down | 63% down | ||
| 24 | BeOne MedicinesONC · Health Care | ZAR 18B | ZAR 799.9B | ZAR 7,002.58 | 0.97% down | 16% up | ||
| 25 | Ascendis PharmaASND · Health Care | ZAR 14B | ZAR 294.1B | ZAR 4,484.32 | 5.32% down | 29% up | ||
| 26 | InsmedINSM · Health Care | ZAR 9.6B | ZAR 555.2B | ZAR 2,530.88 | 20.58% up | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 6B | ZAR 161.5B | ZAR 6,950.73 | 0.34% down | 27% down | ||
| 28 | Legend BiotechLEGN · Health Care | ZAR 5.6B | ZAR 54.7B | ZAR 282.07 | 0.92% down | 41% down | ||
| 29 | CytokineticsCYTK · Health Care | ZAR 5B | ZAR 125.6B | ZAR 901.56 | 0.27% up | 19% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | ZAR 4.3B | ZAR 171.8B | ZAR 1,136.67 | 1.88% down | 117% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | ZAR 3.9B | ZAR 84.6B | ZAR 485.99 | 0.25% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 3.4B | ZAR 216.6B | ZAR 259.82 | 1.00% down | 8% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | ZAR 3.3B | ZAR 125B | ZAR 2,377.06 | 1.25% up | 6% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 1.9B | ZAR 141.9B | ZAR 2,046.29 | 1.88% down | 18% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | ZAR 710.9M | ZAR 70.7B | ZAR 516.48 | 1.24% up | 168% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 17.5196 ZAR). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by total debt?
AbbVie (ZAR 1.18T), Pfizer (ZAR 1.14T) and Merck & Co (ZAR 863.7B) are the top three of the 35 health care pharmaceutical companies ranked by total debt as of 20 Nov 2026, 01:20 UTC.
How many health care pharmaceutical companies are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 35 health care pharmaceutical companies ranked by total debt have a combined market value of ZAR 86.94T as of 20 Nov 2026, 01:20 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.